← All posts

CASP Demo Days Are Next Week. Here Are the Questions Worth Asking.

Informational only; not clinical, legal or compliance advice. Event details can change, so confirm times and registration on CASP's event page before you join.

The Council of Autism Service Providers' Fall 2026 Demo Days are Thursday, November 12 and Friday, November 13, from 12:00 to 2:15 p.m. Eastern each day. It is a virtual event. CASP says each Business Affiliate gets 30 minutes to introduce a product or service, demonstrate it and answer questions from CASP members. You can drop in for the sessions that interest you; one registration covers both days.

That is not a lot of time. A polished demo will fill most of it. The useful part is the leftover Q&A, especially if the product would touch session notes, treatment plans, billing, recordings or any other client information.

Who is on the agenda

CASP's event page lists this schedule (all times Eastern):

CASP describes Business Affiliates as vendors approved through a member-driven review, including a recommendation from a CASP member organization and evaluation by the membership. That is a useful filter. It is not a substitute for your own clinic's review of data handling, contracts or clinical fit.

Questions worth using the Q&A for

These come from CASP's Practice Parameters for Artificial Intelligence Use in Applied Behavior Analysis and from what HHS publishes about business associate contracts. You do not need a product to call itself "AI" for them to matter. If client data goes in, ask.

  1. Where does client data go, and how is it used? CASP says that if you use AI, you need a thorough understanding of how client data entered into the system are stored, analyzed and used. Ask where data live, who can see them, how long they are kept and whether they are used to train or improve a model.
  1. How does the system arrive at an output? CASP tells organizations to hold developers accountable for explaining how the system works. If a tool suggests hours, flags a note or drafts a goal, ask what information informs that output and how a clinician can check it.
  1. Does a person review the output before it becomes part of the record? CASP describes this integration pattern: the tool assists, the provider reviews, and the provider—not the model—goes over the result with the family. Ask whether any output can reach a chart, a payer or a caregiver without a clinician's approval.
  1. Which features would we actually turn on? CASP notes that a product may ship with more features than you should adopt, and that you should review each one for legal and regulatory fit. A demo that shows everything is not a rollout plan.
  1. Can we explain this to a family, and is there a way to decline? CASP ties AI use to informed consent: visibility into how the tool is used, its risks and benefits, and the chance to decline. When possible, the organization should offer a non-AI alternative. If the vendor cannot help you describe the tool in plain language, you are not ready to ask a parent to agree.
  1. Will you execute a business associate agreement we can read? HHS states that the HIPAA Rules generally require covered entities and business associates to enter into contracts so that business associates safeguard protected health information. Ask to see the agreement, which subcontractors it covers, what happens to data when the contract ends, and whether the vendor may de-identify information for other uses. A marketing page that says "HIPAA" is not the same as an agreement you have read.
  1. What do we tell payers? CASP writes that most healthcare funding sources do not address AI for ABA service delivery in their policies, and that organizations should not assume payers will permit or reimburse every use. If a policy is silent and you plan to use the tool for work that is billed directly or bundled into the rate, CASP's guidance is to give the payer a transparent description of the intended use.
  1. Who still owns the documentation? CASP is clear that the practitioner is responsible for clinical documentation and that AI should support clinical work, not replace it. Ask how the product keeps the signing clinician in control, and how you verify that a draft reflects this encounter rather than reused language.
  1. What happens when the model changes? CASP warns that if a vendor retires a version and switches you to a new one, outputs can change—different recommended goals, different audit flags. Ask whether the contract requires notice before deprecation or a material change, and how you will re-check results afterward.

After the 30 minutes

Write the answers down while they are still specific. Bring them to whoever owns your approved-technology list, not just to the person who liked the demo. CASP also asks organizations to plan for staff training so people can critically evaluate outputs, and to monitor and periodically audit the tools they adopt.

A good demo shows you what the product can do. These questions tell you whether it belongs in your clinic.

Sources

More from the blog

Browse the directory of AI tools for ABA · Use cases

Informational only; not legal, clinical or compliance advice. Vendor HIPAA/BAA statements are as published by the vendors and are not verified by us. Sponsorship never changes our rankings. Corrections: admin@gtbehaviorbolts.com.